INS and obesity disorder: Although the inhibition of FFA release by insulin is reduced by weight gain, a recent report has demonstrated that obesity and HFD cause downregulation of β3-adrenergic receptors in adipocytes through elevated inflammatory response, resulting in impaired FFA release from adipose tissue by catecholamines (catecholamine resistance) [66].